Global Newcastle Disease Vaccine Competitive Landscape Professional Research Report 2025
Description
Global Newcastle Disease Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
Newcastle Disease Vaccine is a type of vaccine used to protect poultry, particularly chickens, against Newcastle disease (ND), also known as avian paramyxovirus type 1. Newcastle disease is a highly contagious viral infection that affects birds, causing respiratory, nervous system, and gastrointestinal symptoms. The vaccine is developed using live or inactivated strains of Newcastle disease virus and is administered to chickens via various routes, such as drinking water, spray, or eye drops. The vaccine stimulates the bird’s immune system to produce antibodies against the virus, providing protection and reducing the severity of the disease if the bird is exposed to the ND virus in the future. Newcastle Disease Vaccine plays a crucial role in preventing Newcastle disease outbreaks, ensuring the health and productivity of poultry flocks, and safeguarding the poultry industry.
According to DIResearch's in-depth investigation and research, the global Newcastle Disease Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, Zoetis, DHN, Elanco (Lohmann), ChengDu Tecbond, FATRO, CAVAC, Vaksindo etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Newcastle Disease Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Newcastle Disease Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Newcastle Disease Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Newcastle Disease Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Newcastle Disease Vaccine Include:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
DHN
Elanco (Lohmann)
ChengDu Tecbond
FATRO
CAVAC
Vaksindo
Newcastle Disease Vaccine Product Segment Include:
Live Vaccines
Killed Vaccines
Newcastle Disease Vaccine Product Application Include:
Chicken
Duck & Goose
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Newcastle Disease Vaccine Industry PESTEL Analysis
Chapter 3: Global Newcastle Disease Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Newcastle Disease Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Newcastle Disease Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Newcastle Disease Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Newcastle Disease Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Newcastle Disease Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Newcastle Disease Vaccine Product by Type
- 1.2.1 Live Vaccines
- 1.2.2 Killed Vaccines
- 1.3 Newcastle Disease Vaccine Product by Application
- 1.3.1 Chicken
- 1.3.2 Duck & Goose
- 1.3.3 Other
- 1.4 Global Newcastle Disease Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Newcastle Disease Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Newcastle Disease Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Newcastle Disease Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Newcastle Disease Vaccine Industry Trends and Innovation
- 1.5.1 Newcastle Disease Vaccine Industry Trends and Innovation
- 1.5.2 Newcastle Disease Vaccine Market Drivers and Challenges
- 2 Newcastle Disease Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Newcastle Disease Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Newcastle Disease Vaccine Market Analysis by Regions
- 4.1 Newcastle Disease Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Newcastle Disease Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Newcastle Disease Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Newcastle Disease Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Newcastle Disease Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Newcastle Disease Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Newcastle Disease Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Newcastle Disease Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Newcastle Disease Vaccine Market Size by Type and Application
- 5.1 Global Newcastle Disease Vaccine Market Size by Type
- 5.1.1 Global Newcastle Disease Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Newcastle Disease Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Newcastle Disease Vaccine Market Size by Application
- 5.2.1 Global Newcastle Disease Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Newcastle Disease Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Newcastle Disease Vaccine Market Size by Type
- 6.3.1 North America Newcastle Disease Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 6.4 North America Newcastle Disease Vaccine Market Size by Application
- 6.4.1 North America Newcastle Disease Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 6.5 North America Newcastle Disease Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Newcastle Disease Vaccine Market Size by Type
- 7.3.1 Europe Newcastle Disease Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Newcastle Disease Vaccine Market Size by Application
- 7.4.1 Europe Newcastle Disease Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Newcastle Disease Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Newcastle Disease Vaccine Market Size by Type
- 8.3.1 China Newcastle Disease Vaccine Sales by Type (2020-2032)
- 8.3.2 China Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 8.4 China Newcastle Disease Vaccine Market Size by Application
- 8.4.1 China Newcastle Disease Vaccine Sales by Application (2020-2032)
- 8.4.2 China Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Newcastle Disease Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Newcastle Disease Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Newcastle Disease Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Newcastle Disease Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Newcastle Disease Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Newcastle Disease Vaccine Market Size by Type
- 10.3.1 Latin America Newcastle Disease Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Newcastle Disease Vaccine Market Size by Application
- 10.4.1 Latin America Newcastle Disease Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Newcastle Disease Vaccine Market Size by Country
- 10.6 Latin America Newcastle Disease Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Newcastle Disease Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Newcastle Disease Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Newcastle Disease Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Newcastle Disease Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Newcastle Disease Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Newcastle Disease Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Newcastle Disease Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Newcastle Disease Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Newcastle Disease Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Newcastle Disease Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Merial
- 13.1.1 Merial Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Merial Newcastle Disease Vaccine Product Portfolio
- 13.1.3 Merial Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 CEVA
- 13.2.1 CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CEVA Newcastle Disease Vaccine Product Portfolio
- 13.2.3 CEVA Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 QYH Biotech
- 13.3.1 QYH Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 QYH Biotech Newcastle Disease Vaccine Product Portfolio
- 13.3.3 QYH Biotech Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Ringpu Biology
- 13.4.1 Ringpu Biology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
- 13.4.3 Ringpu Biology Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Yebio
- 13.5.1 Yebio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Yebio Newcastle Disease Vaccine Product Portfolio
- 13.5.3 Yebio Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Harbin Veterinary Research Institute
- 13.6.1 Harbin Veterinary Research Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
- 13.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Merck Animal Health
- 13.7.1 Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
- 13.7.3 Merck Animal Health Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Zoetis
- 13.8.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Zoetis Newcastle Disease Vaccine Product Portfolio
- 13.8.3 Zoetis Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 DHN
- 13.9.1 DHN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 DHN Newcastle Disease Vaccine Product Portfolio
- 13.9.3 DHN Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Elanco (Lohmann)
- 13.10.1 Elanco (Lohmann) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
- 13.10.3 Elanco (Lohmann) Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 ChengDu Tecbond
- 13.11.1 ChengDu Tecbond Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
- 13.11.3 ChengDu Tecbond Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 FATRO
- 13.12.1 FATRO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 FATRO Newcastle Disease Vaccine Product Portfolio
- 13.12.3 FATRO Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 CAVAC
- 13.13.1 CAVAC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 CAVAC Newcastle Disease Vaccine Product Portfolio
- 13.13.3 CAVAC Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Vaksindo
- 13.14.1 Vaksindo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Vaksindo Newcastle Disease Vaccine Product Portfolio
- 13.14.3 Vaksindo Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Newcastle Disease Vaccine Industry Chain Analysis
- 14.2 Newcastle Disease Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Newcastle Disease Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Newcastle Disease Vaccine Typical Downstream Customers
- 14.4 Newcastle Disease Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
